2025-11-12T11:15:16-05:00 2024-12-31 461335331 ALTRUIC ADVISORS CPAS 417 FOREST AVENUE PLYMOUTH MI 48170 990 2024-01-01 208735688 SOLVING KIDS' CANCER INC SOLV 2125886624 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 EYAL SOFFER TREASURER 2125886624 2025-11-08 true false RYAN N HAGAN CPA P00293011 8882985297 2025-11-08 2024 2025-03-06 01:10:19Z EYAL SOFFER 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 394014 false X WWW.SOLVINGKIDSCANCER.ORG X 2006 NY SOLVING KID'S CANCER FINDS, FUNDS AND ADVOCATED FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDERN WITH THE MOST FATAL PEDIATRIC CANCERS. 11 11 3 19 0 657576 274038 0 71862 70757 -88370 -11394 641068 333401 511773 0 0 396921 352724 46200 70940 241608 199818 225559 1154712 649223 -513644 -315822 2075323 1755507 145667 141673 1929656 1613834 X SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE UNTIL LONG-TERM SURVIVAL IS A REALITY FOR ALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS. false false 262005 SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEED WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. 1. SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHIILDREN. THE OBJECTIVES OF THE MEETING ARE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. 2. SKC INITIATED AND FACILITATED THE PEDIATRIC BRAIN TUMOR RESEARCH NETWORK (PBTRN) MEETINGS, BRINGING TOGETHER RESEARCHERS IN THE NYC AREA FROM THE TOP SIX INSTITUTIONS THREE TIMES PER YEAR TO SHARE RESEARCH DATA AND BUILD COLLABORATIONS. 3. SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES. 262005 true true false false false false false false false false true false false true true false true false false false false false false true true false false false false true false false false false false false false false false false false false false false false false false true 5 0 3 true false false false false false true true false false false false false false X 11 11 false false false false false false false true true false false true true true true true true true true false NY X THE ORGANIZATION 2125886624 1 EAST 53RD STREET 8TH FLOOR NEW YORK NY 10022 MARK SAVOYE CO-CHAIR 2.00 X X 0 0 0 CHANNING STAVE CO-CHAIR 2.00 X X 0 0 0 MICHELE ALEXANDER CO-SECRETARY 2.00 X X 0 0 0 CATHERINE MURCHIE CO-SECRETARY 2.00 X X 0 0 0 EYAL SOFFER TREASURER 2.00 X X 0 0 0 KHALIL BARRAGE DIRECTOR 2.00 X 0 0 0 HEARN JAY CHO DIRECTOR 2.00 X 0 0 0 DIALA TABET DIRECTOR 2.00 X 0 0 0 LINDY GAD DIRECTOR 2.00 X 0 0 0 JOHN LONDON DIRECTOR 2.00 X 0 0 0 MICHAEL NIEDZIELSKI DIRECTOR 2.00 X 0 0 0 SCOTT KENNEDY FORMER EXEC 40.00 X 143719 0 13299 143719 13299 1 false true false 12460 261578 274038 70757 70757 49219 12460 60613 -11394 333401 70757 X 143719 114975 14372 14372 166281 77225 44528 44528 19833 12297 3768 3768 22891 14193 4349 4349 33137 33137 70940 70940 74825 74825 9391 9391 875 875 5038 5015 23 18499 18499 7704 385 7319 42930 42930 6517 6517 DUES AND FEES 13083 6411 6672 BANK AND SERVICE CHARGES 6831 820 6011 DIRECT FUNDRAISING EXP 6729 6729 649223 262005 145610 241608 289435 613695 278457 1002545 65000 7642 5081 5818 235490 229552 5938 1302883 134467 119869 2075323 1755507 12668 23272 132999 118401 145667 141673 X 439540 250033 1490116 1363801 1929656 1613834 2075323 1755507 -315822 X false true X true false X 831151 691649 970445 657576 274038 3424859 831151 691649 970445 657576 274038 3424859 56498 3368361 41436 7113 25663 71862 70757 216831 3641690 150109 0.92490 0.88440 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5160 5160 230330 224392 5938 5938 OPERATING LEASE ROU 118401 SECURITY DEPOSITS 1468 119869 OPERATING LEASE LIABILITY 118401 118401 333401 333401 333401 649223 649223 649223 X X true STREETLIGHT DIGITAL 13396 LAFAYETTE WAY THORNTON CO 80241 false 94685 70940 23745 94685 70940 23745 SPRING CELEBRAT 44727 6657 38070 53148 HAMPTONS LUNCHE 16952 5803 11149 7465 61679 12460 49219 60613 60613 -11394 X X X false false false false false false false false false SCOTT KENNEDY FORMER EXEC DIRECTOR 143719 13299 157018 FORM 990 - ORGANIZATION'S MISSION SKC IMPACTS CHILDREN THROUGH THE INITIATION OF CLINICAL RESEARCH TRIALS OF INVESTIGATIVE TREATMENT STRATEGIES. OUR VISION IS TO CONTINUE EXPANDING THE ARMAMENTARIUM OF EFFECTIVE AND LESS TOXIC TREARTMENT STRATEGIES FOR PEDIATRIC ONCOLOGISTCS TO UTILIZE UNTIL LONG-TERM SURVIVAL IS A REALITY FOR ALL CHILDREN WITH HIGH-RISK SOLID TUMORS AND BRAIN TUMORS. TO ACCOMPLISH OUR MISSION, SKC FUNDS AND ADVOCATES FOR BREAKTHROUGH TREATMENT OPTIONS TO IMPROVE SURVIVAL OUTCOMES FOR CHILDREN WITH THE MOST FATAL PEDIATRIC CANCERS THROUGH COLLABORATIVE PARTNERSHIPS WITH THE RESEARCH COMMUNITY AND RELATED NONPROFIT STAKEHOLDERS. FORM 990, PAGE 2, PART III, LINE 4A SKC LEADERSHIP AND SCIENTIFIC ADVISORS SURVEY, DISCUSS, AND PRIORITIZE THE AREAS OF GREATEST UNMET NEED WITHIN THE PEDIATRIC CANCER RESEARCH LANDSCAPE AND DEVELOP SPECIFIC PROGRAMS TO ADDRESS THEM. 1. SKC CONCEIVED AND ORGANIZED THE 2025 CARE FOR RARE GLOBAL STRATEGY FORUM, INVITING THE WORLD'S TOP EXPERTS IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) AND ATYPICAL TERATOID RHABDOID TUMOR (ATRT), TWO RARE AND AGGRESSIVE BRAIN TUMORS THAT AFFECT VERY YOUNG CHIILDREN. THE OBJECTIVES OF THE MEETING ARE TO FACILITATE THE EXCHANGE OF INFORMATION AROUND EXISTING RESEARCH PROJECTS AND BUILD COLLABORATIONS ACROSS CONTINENTS. 2. SKC INITIATED AND FACILITATED THE PEDIATRIC BRAIN TUMOR RESEARCH NETWORK (PBTRN) MEETINGS, BRINGING TOGETHER RESEARCHERS IN THE NYC AREA FROM THE TOP SIX INSTITUTIONS THREE TIMES PER YEAR TO SHARE RESEARCH DATA AND BUILD COLLABORATIONS. 3. SKC HAS ADVISORY ROLES ON NATIONAL AND INTERNATIONAL CLINICAL TRIALS CONSORTIA, REGULATORY BODIES, MULTI STAKEHOLDER PLATFORM FOR PEDIATRIC CANCER DRUG DEVELOPMENT, PHARMACEUTICAL COMPANIES, AND BUILDS COLLABORATIONS WITH OTHER NONPROFITS TO ADVOCATE FOR AND FUND RESEARCH. SKC REVIEWS PROPOSALS FOR THE NCI FUNDED CHILDREN'S ONCOLOGY GROUP AND THE DEPARTMENT OF DEFENSE RARE CANCER RESEARCH PROGRAMMATIC PANEL. SKC WAS INVITED TO SERVE ON PANELS AND PRESENT AT SEVEN SCIENTIFIC MEETINGS IN FIVE COUNTRIES. SKC CO-AUTHORED SEVERAL PEER-REVIEWED JOURNAL ARTICLES AND PEDIATRIC ONCOLOGY TEXTBOOK CHAPTERS. THESE ROLES GIVE SKC OPPORTUNITY TO INFLUENCE RESEARCH AGENDAS AND PRIORITIES. FORM 990, PAGE 6, PART VI, LINE 11B THE COMPLETED FORM 990 IS SENT TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE ORGANIZATION DISTRIBUTES A CONFLICT OF INTEREST POLICY TO EACH BOARD MEMBER ANNUALLY AT THE BOARD MEETING. ALL STAFF AND BOARD MEMBERS ARE REQUIRED TO SIGN A CONFLICT OF INTEREST POLICY STATEMENT. ANY CONFLICTS THAT ARISE DURING THE COURSE OF THE YEAR ARE REQUIRED TO BE DISCLOSED AND RESOLVED BEFORE THE TRANSACTION IS COMPLETED. FORM 990, PAGE 6, PART VI, LINE 15A COMPENSATION IS DETERMINED BY CONDUCTING A FAIR MARKET VALUE COMPARISON OF OTHER ORGANIZATIONS BY THE BOARD CHAIR. FACTORS INCLUDE THE NUMBER OF HOURS WORKED AND THE BREADTH OF ROLES AND RESPONSIBILITIES. FORM 990, PAGE 6, PART VI, LINE 15B COMPENSATION IS DETERMINED BY CONDUCTING A FAIR MARKET VALUE COMPARISON OF OTHER ORGANIZATIONS BY THE BOARD CHAIR. FACTORS INCLUDE THE NUMBER OF HOURS WORKED AND THE BREADTH OF ROLES AND RESPONSIBILITIES. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FORM 990 ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING 0 0 48,000 OTHER CONTRACTED SERVICES 0 0 26,825 TOTAL 0 0 74,825